星空体育官方入口网站网址大全-登录入口官网

#非瓣膜性房颤#

34篇内容 | 1193人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1635331, encodeId=db8116353310c, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, objectType=article, longId=216628, objectId=47192166282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47192166282f, replyNumber=0, likeNumber=48, createdTime=2022-06-10, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47192166282f, moduleTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=47192166282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635329, encodeId=12c8163532961, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, objectType=article, longId=214455, objectId=7be82144553e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be82144553e, replyNumber=0, likeNumber=56, createdTime=2022-02-20, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be82144553e, moduleTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7be82144553e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635330, encodeId=3c64163533008, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？, objectType=article, longId=214673, objectId=3ca32146e3e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ca32146e3e5, replyNumber=0, likeNumber=60, createdTime=2021-10-11, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ca32146e3e5, moduleTitle=对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ca32146e3e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635333, encodeId=ef6e1635333d7, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, objectType=article, longId=219448, objectId=7088219448e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7088219448e5, replyNumber=0, likeNumber=56, createdTime=2022-06-13, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7088219448e5, moduleTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7088219448e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635332, encodeId=0a9c163533224, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, objectType=article, longId=217659, objectId=afdf21e659f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afdf21e659f3, replyNumber=0, likeNumber=58, createdTime=2021-11-17, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afdf21e659f3, moduleTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=afdf21e659f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635328, encodeId=103c1635328f5, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, objectType=article, longId=207827, objectId=3f7620e82759, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7620e82759, replyNumber=0, likeNumber=61, createdTime=2021-08-23, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7620e82759, moduleTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f7620e82759)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635327, encodeId=55b3163532e00, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, objectType=article, longId=205054, objectId=cefe2050546c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cefe2050546c, replyNumber=0, likeNumber=53, createdTime=2021-10-30, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cefe2050546c, moduleTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cefe2050546c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635326, encodeId=692b163532648, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, objectType=article, longId=186699, objectId=44a91866995e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44a91866995e, replyNumber=0, likeNumber=55, createdTime=2021-01-07, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44a91866995e, moduleTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=44a91866995e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635324, encodeId=778416353246b, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, objectType=article, longId=165554, objectId=60da165554b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60da165554b1, replyNumber=0, likeNumber=49, createdTime=2019-05-28, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60da165554b1, moduleTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=60da165554b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635323, encodeId=cd5416353239a, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, objectType=article, longId=156509, objectId=fcba1565093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcba1565093c, replyNumber=0, likeNumber=67, createdTime=2019-01-20, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcba1565093c, moduleTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fcba1565093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635321, encodeId=24401635321fc, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, objectType=article, longId=152787, objectId=9f72152e871d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f72152e871d, replyNumber=0, likeNumber=50, createdTime=2019-05-06, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f72152e871d, moduleTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f72152e871d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635325, encodeId=8cca163532559, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, objectType=article, longId=166308, objectId=02b116630814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b116630814, replyNumber=0, likeNumber=54, createdTime=2019-10-22, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b116630814, moduleTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02b116630814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635322, encodeId=c1331635322d2, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, objectType=article, longId=153169, objectId=dfd415316946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfd415316946, replyNumber=0, likeNumber=52, createdTime=2019-08-27, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfd415316946, moduleTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dfd415316946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635320, encodeId=7620163532058, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？, objectType=article, longId=148742, objectId=9ccd148e4298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ccd148e4298, replyNumber=0, likeNumber=0, createdTime=2019-07-23, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ccd148e4298, moduleTitle=JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9ccd148e4298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635319, encodeId=dd041635319e8, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, objectType=article, longId=134289, objectId=c5a613428989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5a613428989, replyNumber=0, likeNumber=53, createdTime=2018-08-17, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a613428989, moduleTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c5a613428989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635314, encodeId=7772163531471, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Br J Clin Pharmacol：非瓣膜性房颤：利伐沙班可显著减少稳态谷浓度时凝血酶生成？, objectType=article, longId=116513, objectId=8e8f1165138d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e8f1165138d, replyNumber=0, likeNumber=0, createdTime=2018-08-17, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e8f1165138d, moduleTitle=Br J Clin Pharmacol：非瓣膜性房颤：利伐沙班可显著减少稳态谷浓度时凝血酶生成？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8e8f1165138d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635318, encodeId=0132163531846, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, objectType=article, longId=119554, objectId=379c11955440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379c11955440, replyNumber=0, likeNumber=0, createdTime=2018-03-23, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379c11955440, moduleTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=379c11955440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635317, encodeId=fe85163531ec2, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, objectType=article, longId=118856, objectId=23071188567a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23071188567a, replyNumber=0, likeNumber=53, createdTime=2018-06-19, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23071188567a, moduleTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=23071188567a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635315, encodeId=9492163531539, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, objectType=article, longId=117839, objectId=06ed11e83930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ed11e83930, replyNumber=0, likeNumber=0, createdTime=2018-06-18, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ed11e83930, moduleTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=06ed11e83930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1635316, encodeId=fff11635316f0, content=<a href='/topic/show?id=e23f995430c' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤#</a>, objectTitle=J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班, objectType=article, longId=118427, objectId=984711842e9a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=984711842e9a, replyNumber=0, likeNumber=73, createdTime=2018-09-04, rootId=0, userName=12498710m18暂无昵称, userId=e8ff22444815, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=984711842e9a, moduleTitle=J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=984711842e9a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非瓣膜性房颤

2020-05-29

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险

2022-06-10

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局

2022-02-20

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？

2021-10-11

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险

2022-06-13

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效

2021-11-17

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险

2021-08-23

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响

2021-10-30

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响

2021-01-07

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗

2019-05-28

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？

2019-01-20

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系

2019-05-06

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估

2019-10-22

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林

2019-08-27

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？

2019-07-23

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？

2018-08-17

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Br J Clin Pharmacol：非瓣膜性房颤：利伐沙班可显著减少稳态谷浓度时凝血酶生成？

2018-08-17

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？

2018-03-23

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！

2018-06-19

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？

2018-06-18

12498710m18暂无昵称 (审核中...)

前往app查看评论内容

#非瓣膜性房颤#

J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班

2018-09-04

科室
- - 订阅+
  - 更多科室
工具
服务